
Please try another search
Qingdao Baheal Medical INC. engages in the research and development, production, wholesale, and retail of pharmaceutical products in China, the United States, Hong Kong, and the United Kingdom. The company offers bone health drugs under the D-Cal brand name; digestive drugs under the Mite brand name; liver disease drugs under the Fuzhenghuayu brand name; and urological drugs under the Betanli, Harle, and Wei Xi Kang brand names. It also provides ophthalmic drugs under the HYCOSAN brand name; tumor and other severe drugs under the Human Albumin and Xospata brand names; anti-aging and cosmeceuticals under the Quanis, Excellula, TRANSINO, and Qingchunbao brand names; diabetes drugs under the Naida, Feburic, and Naite brand names; respiratory and anti-infective products under the Klacid brand name; and medical nutrition under the Nutrasumma brand name. The company was incorporated in 2005 and is based in Qingdao, China. Qingdao Baheal Medical INC. is a subsidiary of BAHEAL Pharmaceutical Holdings Limited.
Name | Age | Since | Title |
---|---|---|---|
Jun Mou | 52 | 2022 | Chairman of the Supervisory Board |
Qing Song | 57 | 2016 | Non-Independent Director |
Yuan Zhang | 50 | 2017 | Deputy GM & Director |
Haishen Chen | 63 | 2016 | Director |
Xianjing Hao | 60 | 2022 | Independent Director |
Xuebiao Li | 56 | 2019 | Non-Employee Supervisor |
Xiaowei Zhu | 62 | 2016 | Deputy GM & Director |
Yindi Lu | 63 | 2022 | Independent Director |
Nan Du | 42 | 2022 | Employee Supervisor |
Gang Fu | 55 | 2016 | Chairman & GM |
Mingzhong Fu | 75 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review